Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Conditions
Tricuspid Regurgitation · Tricuspid Regurgitation Functional
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cardiovascular Institute of Los Robles Health System, Thousand Oaks, California, United States
Contact: Principal Investigator (Saibal Kar, Dr.)Ascension St. John, Detroit, Michigan, United States
Contact: Principal Investigator (Amir Kaki)Mayo Clinic Hospital (Rochester), Rochester, Minnesota, United States
Contact: Principal Investigator (Mackram F Eleid)Weill Cornell Medicine, New York, New York, United States
Contact: Principal Investigator (Mark Reisman, Dr.)Stony Brook Heart Institute, Stony Brook, New York, United States
Contact: Principal Investigator (Ahmad AlKhalil)The Christ Hospital, Cincinnati, Ohio, United States
Contact: Principal Investigator (Santiago Garcia, Dr)Lankenau Heart Institute, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (William Gray)TriStar Centennial Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Samuel Horr, Dr.)University of Washington Medical Center, Seattle, Washington, United States
Contact: Principal Investigator (James M McCabe)University Medicine Mainz, Mainz, Rhineland-Palatinate, Germany
Contact: Study coordinator (Kim Laura Suder) · Studienzentrum-ZfK@unimedizin-mainz.de · 06131 17 6794Contact: Principal Investigator (Karl Patrik Kresoja, Dr.)Helios Health Institute GmbH, Leipzig, Leipzig, Saxony, Germany
Contact: Study coordinator (Jospehin Kister) · Jospehin.Kister@helios-health-insitute.com · 0341 865 251551Contact: Principal Investigator (Tobias Kister, Dr.)German Heart Center at Charité (DHZC), Berlin, State of Berlin, Germany
Contact: Principal Investigator (Tobias Daniel Trippel, Dr.)